NUP82 Antibody

What is NUP82 and why is it important in cellular research?

NUP82 is an essential yeast nucleoporin of approximately 82 kDa that localizes to the cytoplasmic side of the nuclear pore complex (NPC) . It forms a subcomplex with Nup159 and is required for poly(A)+ RNA export from the nucleus . The significance of NUP82 lies in its specialized role in mRNA export pathways while not affecting classical NLS-mediated nuclear protein import, making it a valuable target for studying specific nuclear transport mechanisms .

Its C-terminal region (approximately 195 amino acids) contains a coiled-coil domain that is critical for its function; deletion of the C-terminal 108 amino acids results in temperature-sensitive growth defects and nuclear accumulation of poly(A)+ RNA . NUP82 antibodies are essential tools for investigating these functions, allowing researchers to study NPC composition, nucleoporin interactions, and mRNA export mechanisms.

What experimental applications are NUP82 antibodies suitable for?

NUP82 antibodies can be employed in multiple experimental techniques:

When selecting a technique, researchers should consider the specific question being addressed and the available antibody's characteristics. For example, immunoelectron microscopy provides greater spatial resolution for determining precise NUP82 localization within the NPC structure, whereas immunofluorescence is more suitable for rapid screening of multiple samples.

How should researchers optimize immunofluorescence protocols for NUP82 detection?

Optimizing immunofluorescence for NUP82 detection requires careful consideration of several parameters:

• Fixation method: For yeast cells, formaldehyde fixation (typically 3.7%) for 30-60 minutes provides good preservation of NPC structures.

• Antibody dilution: Based on the experimental data, primary antibodies detecting epitope-tagged NUP82 (such as HA.11 for HA-tagged NUP82) should be used at approximately 1:2 dilution in appropriate buffer (buffer M has been successfully used) .

• Secondary antibody selection: Fluorophore-conjugated secondary antibodies, such as Cy3-conjugated donkey anti-rabbit IgG at 1:50 dilution, provide strong signal with minimal background .

• Controls: Always include:

  • Negative control (cells without the epitope tag)

  • Positive control (cells expressing a known nucleoporin with similar localization)

  • No-primary-antibody control to assess non-specific binding

• Visualization parameters: Use confocal microscopy to distinguish the characteristic punctate nuclear rim staining pattern of nucleoporins from other nuclear envelope proteins.

For optimal results, researchers should also consider permeabilization conditions carefully, as insufficient permeabilization may prevent antibody access to the nuclear envelope.

What positive and negative controls should be included when using NUP82 antibodies?

Proper controls are essential for reliable interpretation of NUP82 antibody experiments:

When working with epitope-tagged NUP82, researchers should verify that the tag doesn't interfere with protein function by confirming normal growth rates and absence of mRNA export defects in the tagged strain.

How can researchers use NUP82 antibodies to investigate mRNA export mechanisms?

NUP82 antibodies can be powerful tools for investigating mRNA export mechanisms through several sophisticated approaches:

• Correlative microscopy: Combine NUP82 immunolocalization with in situ hybridization for poly(A)+ RNA to correlate NUP82 distribution with mRNA export status. In NUP82-depleted or mutant cells (such as those expressing NUP82-Δ108), nuclear accumulation of poly(A)+ RNA occurs at non-permissive temperatures, indicating export defects .

• Co-immunoprecipitation studies: Use NUP82 antibodies to identify interaction partners involved in mRNA export. This approach has revealed that NUP82 interacts with Nup159, forming a cytoplasmically oriented subcomplex essential for mRNA export .

• Functional rescue experiments: When investigating potential functional relationships, researchers can combine NUP82 depletion with overexpression of potential interacting partners. For example, overexpression of Rss1/Gle1 partially rescues growth defects in cells depleted of NUP82 or Nup159, suggesting a functional relationship in the mRNA export pathway .

• Comparative analysis: Compare the effects of NUP82 depletion with depletion of other nucleoporins on both mRNA export and protein import. Unlike mutations in some nucleoporins that affect both processes, NUP82 depletion specifically affects mRNA export without disrupting classical NLS-mediated protein import .

When designing these experiments, researchers should include appropriate controls and consider the temporal aspects of nucleoporin depletion, as acute versus chronic depletion may yield different phenotypes.

What are the technical challenges when using NUP82 antibodies for immunoelectron microscopy?

Immunoelectron microscopy with NUP82 antibodies presents several technical challenges that researchers must address:

• Sample preparation: Nuclear envelope (NE) preparations must preserve the native structure of NPCs. For yeast cells, gentle isolation of crude nuclear envelopes is critical to maintain structural integrity .

• Epitope accessibility: The cytoplasmic orientation of NUP82 means antibodies must have unobstructed access to this face of the NPC. The preparation method must not create artifacts that block epitope recognition.

• Quantitative analysis: When measuring the distance of gold particles from the center of the NPC (as in the study showing NUP82 at 29.9 nm with SD of 10.9 nm), researchers must:

  • Establish clear criteria for identifying NPCs in cross-section

  • Develop consistent measurement protocols

  • Account for the flexibility of cytoplasmic filaments (the large standard deviation suggests NUP82 is located on mobile filamentous structures)

• Data interpretation: Distinguishing specific from non-specific labeling requires careful analysis. Gold particles should be counted only when "unequivocally associated with NPCs" .

• Multi-labeling experiments: When attempting to co-localize NUP82 with other nucleoporins (such as Nup159), researchers must carefully select antibodies raised in different species and appropriate sized gold particles for each secondary antibody.

To overcome these challenges, researchers should optimize fixation conditions, antibody concentrations, and incubation times specifically for electron microscopy applications, which differ from those used in light microscopy.

How can researchers distinguish between direct and indirect effects when studying NUP82 mutants?

Distinguishing direct from indirect effects in NUP82 mutant studies requires systematic experimental approaches:

• Temporal analysis: Monitor cellular changes immediately following conditional inactivation of NUP82 (e.g., using temperature-sensitive mutants like NUP82-Δ108). Primary effects typically manifest before secondary consequences .

• Structure-function analysis: Create a panel of truncation or point mutants affecting different domains of NUP82. For example:

  • C-terminal truncations of different lengths (Δ87 versus Δ108) produce phenotypes of varying severity

  • This approach helps map functional domains and separate different functions

• Suppressor analysis: Identify genes that, when overexpressed, suppress NUP82 mutant phenotypes. For instance, overexpression of Rss1/Gle1 partially rescues growth defects in NUP82-depleted cells, suggesting a functional relationship .

• Comparative phenotypic analysis: Compare phenotypes between different nucleoporin mutants. The specificity of the mRNA export defect without protein import defects in NUP82 mutants helps distinguish its primary functions .

• Ultrastructural analysis: Determine whether NPC structure is grossly affected in NUP82 mutants. The observation that NUP82-Δ108 cells don't display gross morphological defects in their NPCs or nuclear envelopes at restrictive temperature suggests mRNA export defects are not due to general NPC structural failure .

When designing these experiments, researchers should be mindful that nucleoporins often have multiple functions, and mutation of one domain may not affect all functions equally.

What considerations are important when designing epitope-tagged NUP82 constructs?

Successful epitope tagging of NUP82 requires careful design considerations to maintain protein functionality:

• Tag position: Based on published research, C-terminal epitope tagging has been successfully implemented for NUP82 . Consider:

  • The C-terminal coiled-coil domain (last 195 amino acids) is functionally important, so tags must not disrupt this structure

  • N-terminal tagging could be an alternative if C-terminal tagging affects function

• Tag selection:

  • HA epitope tags have been successfully used for NUP82 detection

  • Consider using tandem epitopes (e.g., 2xHA) to enhance detection sensitivity

• Expression control:

  • Expressing tagged NUP82 from its endogenous promoter helps maintain physiological expression levels

  • Plasmid-based expression systems should include the natural promoter region

• Validation steps:

  • Confirm that tagged NUP82 complements the null mutant phenotype

  • Verify normal growth rates at various temperatures

  • Check for absence of mRNA export defects

  • Confirm proper localization to the nuclear rim

• Strain construction strategy:

  • For complete replacement, create a strain with genomic copies of NUP82 disrupted, harboring a plasmid that expresses the tagged version

  • For partial replacement, maintain the endogenous copy while expressing the tagged version

The successful tagging approach described in the literature involved ligating a PCR product of the endogenous promoter and coding sequence of NUP82 into a plasmid containing two tandem copies of the DNA encoding the HA epitope fused in frame at the 3' end of the gene (plasmid pNUP82-2Ix) .

What methods are most effective for studying NUP82 protein interactions?

Several complementary approaches can be used to study NUP82 protein interactions:

For overlay assays specifically, the protocol used in the literature involves:

• Expressing GST or GST-Nup82 fusion proteins in bacteria (BLR(DE3))

• Inducing protein expression with IPTG (50 μM) for 1 hour at 37°C

• Cell lysis by freeze-thaw and sonication in transport buffer with protease inhibitors

• Incubating the lysate with protein blots

• Detecting bound GST-Nup82 using rabbit polyclonal anti-GST antibody

This combined approach revealed that Nup82 interacts with the C-terminal region of Nup159, forming a cytoplasmically oriented subcomplex that likely constitutes part of the fibers emanating from the cytoplasmic ring of the NPC .

How can researchers assess whether NUP82 antibodies are detecting specific protein complexes?

Validating the specificity of protein complexes detected by NUP82 antibodies requires several control experiments:

• Mutant analysis: Compare complexes detected in wild-type cells versus cells expressing mutant forms of NUP82 (e.g., NUP82-Δ108). Differences in complex formation can reveal functionally important interactions .

• Reciprocal immunoprecipitation: If NUP82 interacts with protein X, then antibodies against protein X should co-precipitate NUP82. This was demonstrated with the Nup82-Nup159 interaction .

• Competition assays: Pre-incubation with purified recombinant proteins should reduce the co-precipitation of the corresponding endogenous proteins if the interaction is specific.

• Domain mapping: Generate truncated versions of NUP82 to identify which domains are required for specific interactions. The C-terminal coiled-coil domain (last 195 amino acids) is implicated in protein-protein interactions .

• Cross-validation with other techniques: Confirm interactions identified by co-immunoprecipitation using alternative methods such as in vitro binding assays. For example, GST-Nup82 was shown to interact with Nup159 using overlay conditions .

• Controls for non-specific binding:

  • Use pre-immune serum or isotype control antibodies

  • Include samples from cells not expressing the target protein

  • Test binding to irrelevant GST fusion proteins

When interpreting results, researchers should consider that the large standard deviation in NUP82 localization (10.9 nm from the NPC center) suggests it's located on filamentous structures that may be mobile during purification, potentially affecting interaction detection .

What are common challenges when using NUP82 antibodies and how can they be overcome?

Researchers frequently encounter several challenges when working with NUP82 antibodies:

• Background signal in immunofluorescence:

  • Problem: Non-specific nuclear envelope staining

  • Solution: Increase blocking time (use 5% milk or BSA), optimize antibody dilution, and include detergents (0.1-0.5% Triton X-100) in wash buffers

• Poor signal in immunoelectron microscopy:

  • Problem: Low labeling efficiency

  • Solution: Optimize fixation conditions, use gold particles of appropriate size (10 nm works well for NUP82), and ensure proper sample preparation of nuclear envelopes

• Inconsistent immunoprecipitation results:

  • Problem: Variable co-precipitation of interaction partners

  • Solution: Standardize lysis conditions, adjust salt concentration in buffers (interactions may be salt-sensitive), and use freshly prepared lysates

• Cross-reactivity with other nucleoporins:

  • Problem: Antibodies recognizing unintended targets

  • Solution: Pre-absorb antibodies against lysates from knockout strains, use epitope-tagged versions of NUP82, and validate with multiple antibodies

• Detection of degradation products:

  • Problem: Multiple bands in Western blots, especially with mutant forms

  • Solution: Include protease inhibitors during sample preparation and analyze freshly prepared samples (mutant forms like NUP82-Δ108 are known to be unstable at restrictive temperatures)

• Variability in localization measurements:

  • Problem: Large standard deviations in distance measurements from NPC center

  • Solution: Increase sample size, standardize measurement protocols, and consider the natural flexibility of cytoplasmic filaments when interpreting results

For temperature-sensitive mutants like NUP82-Δ108, researchers should carefully control temperature shifts and collection times, as the protein rapidly degrades at non-permissive temperatures .

How can researchers effectively use NUP82 antibodies to study nuclear transport dynamics?

To effectively study nuclear transport dynamics using NUP82 antibodies, researchers should implement these methodological approaches:

• Real-time imaging: For dynamic studies, consider:

  • Creating GFP-tagged NUP82 constructs for live-cell imaging

  • Using the NLS-GFP assay system described in the literature to monitor nuclear import kinetics in NUP82 mutant backgrounds

  • Implementing FRAP (Fluorescence Recovery After Photobleaching) to measure mobility

• Cargo-specific transport assays:

  • For mRNA export: Use in situ hybridization with oligo(dT) probes to monitor poly(A)+ RNA localization in NUP82 mutant cells

  • For protein import: Employ the NLS-GFP assay, which involves:

    • Expressing NLS-GFP constitutively

    • Treating cells with metabolic inhibitors (10 mM NaN₃, 10 mM 2-deoxyglucose) to block active transport

    • Allowing NLS-GFP to equilibrate throughout the cell

    • Washing out inhibitors and monitoring nuclear reimport kinetics

    • Quantifying the percentage of cells showing nuclear localization over time

• Conditional depletion systems:

  • Use temperature-sensitive mutants like NUP82-Δ108 to rapidly inactivate NUP82 function

  • Monitor transport kinetics at different time points after temperature shift

  • Compare early versus late effects to distinguish primary from secondary consequences

• Combined immunolocalization and functional assays:

  • Simultaneously visualize NUP82 (using specific antibodies) and transport substrates

  • Correlate changes in NUP82 localization or levels with transport efficiency

  • Consider dual-color imaging approaches for co-localization studies

The data clearly demonstrate that NUP82 is specifically required for mRNA export but not for classical NLS-mediated protein import, making it a valuable tool for dissecting the molecular mechanisms that distinguish these transport pathways .

How do antibodies against yeast NUP82 compare with those targeting mammalian homologs?

When comparing antibodies against yeast NUP82 with those targeting its putative mammalian functional homologs, researchers should consider several important factors:

• Homology considerations:

  • NUP82 has no direct sequence homolog in mammals, but Nup88 is considered its functional homolog based on domain structure (C-terminal coiled-coil) and interaction with Nup214 (the mammalian homolog of Nup159)

  • Cross-reactivity between species is therefore unlikely, and separate antibodies must be developed

• Structural conservation:

  • Both yeast NUP82 and mammalian Nup88 form subcomplexes with proteins located on the cytoplasmic side of the NPC

  • Both are components of cytoplasmic filaments emanating from the NPC

  • Antibodies against conserved structural domains might show limited cross-reactivity

• Experimental applications comparison:

• Functional equivalence:

  • Both are involved in mRNA export pathways

  • Evidence from complementation studies (if available) would help establish functional equivalence

  • The Nup214/Nup88 mammalian subcomplex is considered homologous to the Nup159/Nup82 yeast subcomplex

• Disease relevance:

  • Mammalian Nup214 was originally identified as CAN, an oncogene in certain leukemias

  • Antibodies against mammalian nucleoporins may have additional applications in cancer research

These comparative considerations are essential when researchers aim to translate findings from yeast models to mammalian systems or when designing experiments to address evolutionary conservation of nuclear transport mechanisms.

What emerging technologies might enhance the utility of NUP82 antibodies in research?

Emerging technologies offer exciting opportunities to expand the applications of NUP82 antibodies in nuclear transport research:

• Super-resolution microscopy: Techniques such as STORM, PALM, or STED microscopy could provide nanometer-scale resolution of NUP82 localization within the NPC, improving upon the measurements obtained by conventional immunoelectron microscopy (which placed NUP82 at 29.9 nm from the NPC center) .

• Single-molecule tracking: By combining photoactivatable fluorescent protein tags with single-molecule tracking, researchers could monitor the dynamics of individual NUP82 molecules, providing insights into their mobility and interactions within the NPC.

• Proximity labeling approaches: Technologies like BioID or APEX2 fused to NUP82 could identify proteins in close proximity to NUP82 in living cells, expanding our understanding of its interaction network beyond what antibody-based co-immunoprecipitation has revealed.

• Cryo-electron tomography: This technique could provide structural information about NUP82's positioning within the intact NPC at molecular resolution, complementing the immunoelectron microscopy data that localized NUP82 to the cytoplasmic side of the NPC .

• Quantitative proteomics: Combining immunoprecipitation with mass spectrometry could identify the complete interactome of NUP82 under different cellular conditions, building upon the known interactions with Nup159 and Nsp1 .

• CRISPR-based approaches: Genome editing could facilitate endogenous tagging of NUP82, enabling more physiologically relevant imaging and interaction studies without the need for overexpression systems.

These technological advances will help address remaining questions about how the cytoplasmically oriented NUP82/Nup159 subcomplex specifically facilitates mRNA export without affecting protein import, potentially revealing new mechanisms in nucleocytoplasmic transport regulation.